Sherif Sharaby

Statistics

Publications

Citations

H-Index

Active since

2023

Affiliations

Sherif Sharaby is an author at Massachusetts General Hospital specializing in pharmacodynamics of anticancer agents, dose-escalation designs, and dose escalation therapy.

ORCID

Publications per year

2023–2025

Publications

A Phase I Dose-Escalation Study of the HIF-2 Alpha Inhibitor DFF332 in Patients with Advanced Clear-Cell Renal Cell Carcinoma

Sumanta K. Pal, Alice Bernard‐Tessier, Peter Grell et al. · Clinical Cancer Research · 2025 · 18 citations · Full text

Medicine, Oncology, Pharmacology +14

Reciprocal stabilization of coagulation factor XIII-A and -B subunits is a determinant of plasma FXIII concentration

James R. Byrnes, Taek Lee, Sherif Sharaby et al. · Blood · 2023 · 11 citations · Full text

Medicine, Biochemistry, Hematology +16

1–2 of 2